Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons
Yan Rao, … , Tamas L. Horvath, Xiao-Bing Gao
Yan Rao, … , Tamas L. Horvath, Xiao-Bing Gao
Published December 3, 2007
Citation Information: J Clin Invest. 2007;117(12):4022-4033. https://doi.org/10.1172/JCI32829.
View: Text | PDF
Research Article

Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons

  • Text
  • PDF
Abstract

Sleep is a natural process that preserves energy, facilitates development, and restores the nervous system in higher animals. Sleep loss resulting from physiological and pathological conditions exerts tremendous pressure on neuronal circuitry responsible for sleep-wake regulation. It is not yet clear how acute and chronic sleep loss modify neuronal activities and lead to adaptive changes in animals. Here, we show that acute and chronic prolonged wakefulness in mice induced by modafinil treatment produced long-term potentiation (LTP) of glutamatergic synapses on hypocretin/orexin neurons in the lateral hypothalamus, a well-established arousal/wake-promoting center. A similar potentiation of synaptic strength at glutamatergic synapses on hypocretin/orexin neurons was also seen when mice were sleep deprived for 4 hours by gentle handling. Blockade of dopamine D1 receptors attenuated prolonged wakefulness and synaptic plasticity in these neurons, suggesting that modafinil functions through activation of the dopamine system. Also, activation of the cAMP pathway was not able to further induce LTP at glutamatergic synapses in brain slices from mice treated with modafinil. These results indicate that synaptic plasticity due to prolonged wakefulness occurs in circuits responsible for arousal and may contribute to changes in the brain and body of animals experiencing sleep loss.

Authors

Yan Rao, Zhong-Wu Liu, Erzsebet Borok, Rebecca L. Rabenstein, Marya Shanabrough, Min Lu, Marina R. Picciotto, Tamas L. Horvath, Xiao-Bing Gao

×

Figure 7

Occlusion of For-LTP in hypocretin/orexin neurons in mice exposed to prolonged wakefulness.

Options: View larger image (or click on image) Download as PowerPoint
Occlusion of For-LTP in hypocretin/orexin neurons in mice exposed to pro...
(A) Time courses indicate that For-LTP of mEPSC frequency existed in control and modafinil-treated mice. (B) Time courses indicate that For-LTP of mEPSC amplitude is significantly attenuated in modafinil-treated mice compared with control mice (P < 0.05, Student’s t test). (C and D) Cumulative probability of mEPSC amplitude detected before and 30 minutes after the treatment of forskolin in control (C) and modafinil-treated mice (D) confirms a significant enhancement after the treatment of forskolin (P < 0.001, Kolmogorov-Smirnov test). (C) Control, 1,101 events; forskolin treatment, 1,770 events. (D) Control, 1,282 events; forskolin treatment, 2,387 events. (E–H) LTP of mEPSC frequency and amplitude triggered by forskolin is occluded in mice acutely exposed to modafinil. (E) LTP of mEPSC frequency is significantly attenuated in modafinil-treated compared with control mice (P < 0.05, Student’s t test). (F) LTP of mEPSC amplitude induced by forskolin (5 μM) exists in control mice but not in modafinil-treated mice. (G and H) Cumulative probability of mEPSC amplitude detected before and 30 minutes after the treatment with forskolin in control (G) and modafinil-treated mice (H). (G) A significant potentiation induced by forskolin is confirmed (P < 0.001, Kolmogorov-Smirnov test). Control: 1,124 events; forskolin treatment: 1,666 events. (H) No significant changes in mEPSC amplitude are detected after the treatment with forskolin (P > 0.05, Kolmogorov-Smirnov test). Control: 516 events; forskolin treatment: 723 events.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts